Inhibition of Bone Marrow-Mesenchymal Stem Cell-Induced Carbonic Anhydrase IX Potentiates Chemotherapy Efficacy in Triple-Negative Breast Cancer Cells

Conventional chemotherapy represents the main systemic treatment used for triple-negative breast cancer (TNBC) patients, although many of them develop drug resistance. The hypoxic TME is the crucial driver in the onset of insensitivity to chemotherapy. In this research, we elucidated the role played...

Full description

Bibliographic Details

Published in:	Cells
Main Authors:	Annachiara Sarnella, Ylenia Ferrara, Sandra Albanese, Daniela Omodei, Laura Cerchia, Giuseppina De Simone, Claudiu T. Supuran, Antonella Zannetti
Format:	Article
Language:	English
Published:	MDPI AG 2023-01-01
Subjects:	tumor microenvironment bone-marrow-mesenchymal stem cells triple-negative breast cancer carbonic anhydrase IX
Online Access:	https://www.mdpi.com/2073-4409/12/2/298